Pharma Foods International Co., Ltd.

Tokyo Stock Exchange 2929.T

Pharma Foods International Co., Ltd. Market Capitalization on January 14, 2025: USD 170.28 M

Pharma Foods International Co., Ltd. Market Capitalization is USD 170.28 M on January 14, 2025, a -18.82% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Pharma Foods International Co., Ltd. 52-week high Market Capitalization is USD 209.92 M on July 30, 2024, which is 23.28% above the current Market Capitalization.
Pharma Foods International Co., Ltd. 52-week low Market Capitalization is USD 146.16 M on April 19, 2024, which is -14.16% below the current Market Capitalization.
Pharma Foods International Co., Ltd. average Market Capitalization for the last 52 weeks is USD 173.53 M.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Tokyo Stock Exchange: 2929.T

Pharma Foods International Co., Ltd.

CEO	Mr. Mu Jo Kim
IPO Date	June 12, 2006
Location	Japan
Headquarters	1-49 Goryo-Ohara
Employees	642
Sector	Health Care
Industries Pharmaceuticals Biotechnology Consumer Packaged Goods

Description

Pharma Foods International Co., Ltd. engages in the development and sale of functional food ingredients in Japan. Its products include Pharma-GABA, Bonepep, Ovopron (egg yolk globulin), Delicious Catechin, RunPep, and enriched Folic Acid Egg, as well as iHA, a substance that stimulates secretion of hyaluronic acid. Pharma Foods International Co., Ltd. has licensing agreement with Mitsubishi Tanabe Pharma Corporation for a new therapeutic antibody to treat autoimmune diseases. Pharma Foods International Co., Ltd. was founded in 1997 and is based in Kyoto, Japan.

Key trends

Past 5 years